Here are five things you need to know for Tuesday, December 29:
1. – Stock Futures indicates more Wall Street records
In the long run, futures traded on Tuesday and headed for more records, as Wall Street gained optimism from President Donald Trump’s signing of the coronavirus aid package.
Dow Jones industrial average contracts rose 113 points, S&P 500 futures rose 14 points, and Nasdaq futures rose 45 points.
Stocks closed Monday after Trump signed a $ 2.3 trillion spending bill late Sunday, which includes nearly $ 1 trillion in coronavirus relief. The Dow rose 204 points, or 0.68%, to 30,403, the S&P 500 rose 0.87% to 3,735, and the Nasdaq gained 0.74% to 12,899.
Late Monday, the House of Representatives passed a bill that would increase incentive controls for Americans to $ 2,000 from $ 600 of legislation Trump has signed into law. The President supported the proposal.
The bill is now heading to the Senate. Mitch McConnell, the leader of the Senate majority, did not say whether the upper house will vote on the increase in payments.
2. – Nikkei 225 from Japan hits 30 years
Shares in Asia ended on Tuesday, and the Japanese Nikkei 225 index reached a 30-year high after US President Trump signed the economic aid package.
Tokyo’s Nikkei 225 rose 2.7% to 27,568.15, the first time it has traded more than 27,000 since August 1990, according to FactSet.
For more information on Asian markets, read:
The US is tightening its ban on Chinese military-related companies
3. – The Boeing 737 MAX will fly again on Tuesday
Boeing (nay) – Get the report 737 MAX, bound since March 2019 after two fatal accidents, will fly again with paying passengers on Tuesday.
American Airlines’ (AAL) – Get the report Flight 718 should leave Miami around 10:30 a.m. ET and arrive at New York LaGuardia at 1:30 p.m., USA Today reported.
The Federal Aviation Administration approved a return to service for 737 MAX last month. FAA Administrator Steven Dickson said at the time he was “100% confident” in the safety of the aircraft, after canceling the 20-month-old order that would allow the plane to resume commercial flights.
The two 737 MAX crashes in Ethiopia and Indonesia, which killed 346 people, were eventually linked to the jet navigation system.
United airlines (UAL) – Get the report said it expects to resume MAX flights on February 11th.
Boeing shares rose 0.81% on Tuesday to $ 217.83.
4. – Coronavirus – The latest
The number of global deaths confirmed by Covid-19, the disease caused by coronavirus, 1,775,661, according to Johns Hopkins University. Confirmed cases of the virus worldwide have risen to over 81.3 million.
The death toll in the United States is 334,963, the highest in the world. The number of infected people confirmed in the US was 19,308,467.
According to university data, there were 150,092 new cases of coronavirus and 1,209 deaths in the United States.
Hospitalizations related to Covid-19, the disease caused by coronavirus, reached news heights on Monday.
Health officials in Southern California on Tuesday are likely to extend home stay orders as the intensive care unit’s capacity has dropped to 0%, Gov. Gavin Newsom said.
The governor said more than 261,672 doses of the vaccine have been given in California so far, Bloomberg reported. He said that by the end of the week the state should have received all 904,000 Modern (mRNA) – Get the report vaccine doses and 858,000 Pfizer (FE) – Get the report the doses the state expected to have at this time.
5. – Novavax begins the Phase 3 trial with the Covid-19 vaccine
(NVAX) – Get the report (NVAX) – Get the report began a phase 3 clinical trial of his experimental Covid-19 vaccine on up to 30,000 people at 115 sites in the United States and Mexico.
The Novavax image will become the fifth vaccine to enter final testing in the United States. (JNJ) – Get the report and AstraZeneca (AZN) – Get the report they are in large-scale trials.
If the results of the Novavax study are positive, the vaccine could be approved sometime in 2021.
“We’ve come this far, so fast, but we need to get to the finish line,” Francis S. Collins, director of the National Institutes of Health, which helps fund the Novavax study, told the Wall Street Journal. This will require more vaccines using different approaches to ensure that everyone is safely and effectively protected from this deadly disease.
In addition to NIH support, the Novavax study will receive $ 1.6 billion from the Advanced Biomedical Research and Development Authority, which is part of the US Department of Health and Human Services.
Shares of Novavax in Gaithersburg, Maryland, fell 0.73% on Tuesday to $ 116. The stock decreased by 9.66% on Monday.